Free Trial

Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)
Free ALPMY Stock Alerts
$9.55
+0.01 (+0.10%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest

Astellas Pharma Short Interest Data

Current Short Volume
69,800 shares
Previous Short Volume
171,800 shares
Change Vs. Previous Month
-59.37%
Dollar Volume Sold Short
$647,150.70
Short Interest Ratio / Days to Cover
0.1
Last Record Date
April 15, 2024
Outstanding Shares
1,809,660,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
452,047 shares
Average Trading Volume
301,920 shares
Today's Volume Vs. Average
150%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Astellas Pharma ?

Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short InterestDays to CoverShort Percent of Float

ALPMY Short Interest Over Time

ALPMY Days to Cover Over Time

ALPMY Percentage of Float Shorted Over Time

Astellas Pharma Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27
3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75
3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83
2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93
2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05
1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08
12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90
12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36
11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16
11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65
10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69
10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04
9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85
9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91
8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14
8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13
7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63
7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40
6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87
6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12
5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77
5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03
4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02
4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81
3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20
3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77
2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00
2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37
1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68
1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62
12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16
12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57
11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46
11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07
10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86
10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33
9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33
9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77
8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30
7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

ALPMY Short Interest - Frequently Asked Questions

What is Astellas Pharma's current short interest?

Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 69,800 shares of ALPMY short. Learn More on Astellas Pharma's current short interest.

Is Astellas Pharma's short interest increasing or decreasing?

Astellas Pharma saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 69,800 shares, a decrease of 59.4% from the previous total of 171,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Astellas Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Astellas Pharma: BioMarin Pharmaceutical Inc. (1.96%), Alnylam Pharmaceuticals, Inc. (1.98%), Teva Pharmaceutical Industries Limited (1.04%), Genmab A/S (0.40%), Viatris Inc. (3.55%), BeiGene, Ltd. (1.92%), Merck KGaA (0.43%), Karuna Therapeutics, Inc. (5.16%), Dr. Reddy's Laboratories Limited (0.45%), Sarepta Therapeutics, Inc. (5.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Astellas Pharma stock?

Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Astellas Pharma?

A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further.

How often is Astellas Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is April, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (OTCMKTS:ALPMY) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Man Who Predicted 2008: “This Will be Worse.”
Altimetry